However, prophylactic (i.e. before initiating antigenic exposure) antibody-mediated depletion of CD4+ T cells in experimental HP causes modifications of leukocyte populations in the airways but fails to inhibit neutrophilic inflammation [2, 3], suggesting that specific targeting of T cells is challenging and likely insufficient for HP therapy. The gene discussed is CD4; the disease is hypersensitivity pneumonitis.